Oppenheimer Asset Management Inc. Pacira Bio Sciences, Inc. Transaction History

Oppenheimer Asset Management Inc.

$7.94 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$35.53 - $43.38 $33,540 - $40,950	944 Added 10.93%	9,579 $390,000
Q4 2022 Feb 06, 2023	SELL	$38.19 - $57.45 $151,537 - $227,961	-3,968 Reduced 31.48%	8,635 $333,000
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $68,559 - $78,794	-1,338 Reduced 9.6%	12,603 $670,000
Q2 2022 Aug 08, 2022	SELL	$51.49 - $81.64 $278,715 - $441,917	-5,413 Reduced 27.97%	13,941 $813,000
Q1 2022 May 12, 2022	SELL	$60.03 - $76.49 $41,420 - $52,778	-690 Reduced 3.44%	19,354 $1.48 Million
Q4 2021 Feb 02, 2022	SELL	$47.97 - $62.21 $59,338 - $76,953	-1,237 Reduced 5.81%	20,044 $1.21 Million
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $100,756 - $113,037	1,844 Added 9.49%	21,281 $1.19 Million
Q2 2021 Aug 03, 2021	BUY	$59.18 - $69.99 $208,372 - $246,434	3,521 Added 22.12%	19,437 $1.18 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $195,841 - $260,263	3,302 Added 26.18%	15,916 $1.12 Million
Q4 2020 Feb 11, 2021	BUY	$50.47 - $66.26 $249,776 - $327,920	4,949 Added 64.57%	12,614 $755,000
Q3 2020 Nov 13, 2020	BUY	$51.97 - $63.0 $159,028 - $192,780	3,060 Added 66.45%	7,665 $461,000
Q2 2020 Aug 11, 2020	BUY	$30.8 - $52.47 $95,911 - $163,391	3,114 Added 208.85%	4,605 $242,000
Q1 2020 May 08, 2020	BUY	$28.4 - $50.7 $25,474 - $45,477	897 Added 151.01%	1,491 $50,000
Q4 2019 Feb 07, 2020	SELL	$36.31 - $46.83 $4,466 - $5,760	-123 Reduced 17.15%	594 $27,000
Q3 2019 Oct 31, 2019	SELL	$35.66 - $44.99 $251,367 - $317,134	-7,049 Reduced 90.77%	717 $27,000
Q2 2019 Aug 09, 2019	SELL	$36.57 - $47.97 $6,399 - $8,394	-175 Reduced 2.2%	7,766 $338,000
Q1 2019 Apr 24, 2019	BUY	$36.47 - $42.17 $6,856 - $7,927	188 Added 2.42%	7,941 $302,000
Q4 2018 Jan 30, 2019	SELL	$41.31 - $52.16 $58,247 - $73,545	-1,410 Reduced 15.39%	7,753 $333,000
Q3 2018 Oct 26, 2018	SELL	$32.85 - $52.0 $3,219 - $5,096	-98 Reduced 1.06%	9,163 $450,000
Q2 2018 Aug 10, 2018	SELL	$27.5 - $39.8 $71,527 - $103,519	-2,601 Reduced 21.93%	9,261 $297,000
Q1 2018 May 09, 2018	BUY	$29.98 - $46.35 $134,520 - $207,972	4,487 Added 60.84%	11,862 $370,000
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $263,287 - $291,312	7,375	7,375 $277,000

Others Institutions Holding PCRX

# of Institutions

260

Shares Held

49.8M

Call Options Held

1.03M

Put Options Held

139K

Black Rock Inc. New York, NY

8.01M
Shares

$185 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.26M
Shares

$122 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

3.26M
Shares

$75.4 Million
0.15% of portfolio
D. E. Shaw & Co., Inc. New York, NY

2.26M
Shares

$52.1 Million
0.03% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.99M
Shares

$46 Million
0.06% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.06B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account